drugset
drugset / Trial / NCT06533605

Phase I Clinical Study to Evaluate the Safety and Efficacy of SSGJ-706 Monotherapy for Patients With Advanced Solid Tumors

NCT06533605 ↗

Phase 1 Unknown 60 enrolled Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study includes two parts, different part has different administration frequencies of SSGJ-706.

Timeline

Start
2024-08
Primary completion
2025-07-30
Completion
2025-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject SSGJ-706 Unknown — —

Indications

neoplasm